share_log

This Moderna Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

Benzinga ·  Aug 28 21:39

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Citigroup analyst Douglas Irwin upgraded the rating for Delek Logistics Partners, LP (NYSE:DKL) from Neutral to Buy and raises the price target from $44 to $45. Delek Logistics Partners shares fell 0.4% to close at $38.83 on Tuesday. See how other analysts view this stock.
  • B of A Securities analyst Ruplu Bhattacharya upgraded Concentrix Corporation (NASDAQ:CNXC) from Underperform to Neutral and boosted the price target from $65 to $85. Concentrix shares rose 0.9% to close at $72.34 on Tuesday. See how other analysts view this stock.
  • HSBC analyst Yifeng Liu upgraded the rating for Moderna, Inc. (NASDAQ:MRNA) from Reduce to Hold and announced a price target of $82. Moderna shares fell 3.3% to close at $78.98 on Tuesday. See how other analysts view this stock.
  • Deutsche Bank analyst Bastian Synagowitz upgraded ArcelorMittal S.A. (NYSE:MT) from Hold to Buy and raised the price target from $29 to $31. ArcelorMittal shares gained 0.3% to settle at $23.47 on Tuesday. See how other analysts view this stock.
  • Baird analyst Peter Arment upgraded the rating for AeroVironment, Inc. (NASDAQ:AVAV) Neutral to Outperform and raised the price target from $161 to $220. AeroVironment shares rose 6.1% to close at $177.76 on Tuesday. See how other analysts view this stock.

Considering buying MRNA stock? Here's what analysts think:

big
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment